Home » Stada Widens Biotech Drug Offering With Filgrastim License
Stada Widens Biotech Drug Offering With Filgrastim License
German generic drugmaker Stada said that it will begin selling a version of Amgen’s cancer drug filgrastim across almost all of the EU.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May